David D Cuthbertson Selected Research

Ultralente Insulin

8/2005

Effect of low-dose insulin treatment on body weight and physical development in children and adolescents at risk for type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David D Cuthbertson Research Topics

Disease

5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 03/2002
1	Seizures (Absence Seizure) 10/2022
1	Cysts 10/2022
1	Insulin Resistance 10/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2018
1	Dermatomyositis (Dermatopolymyositis) 12/2018
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2018
1	Bradycardia 01/2006
1	Body Weight (Weight, Body) 08/2005

Drug/Important Bio-Agent (IBA)

4	AutoantibodiesIBA 10/2021 - 03/2002
3	AntibodiesIBA 08/2004 - 03/2002
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 01/2003
2	Insulin (Novolin)FDA Link 08/2005 - 01/2003
2	Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2003 - 03/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2022
1	hexacosanoic acidIBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	C-PeptideIBA 10/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2018
1	GlucocorticoidsIBA 12/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2006
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2006
1	Ultralente Insulin FDA Link 08/2005
1	ICA512 autoantibodyIBA 01/2003
1	Proteins (Proteins, Gene)FDA Link 03/2002
1	Tyrosine (L-Tyrosine)FDA Link 03/2002
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2002
1	AutoantigensIBA 03/2002
1	EpitopesIBA 03/2002